-
Kyruus to Power Boston Children’s Hospital’s Next Phase of Digital Transformation
May 13, 2020, 10:46 AM by Michael CroftBOSTON, MA, UNITED STATES - May 13, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Boston Childrens Hospital, the top pediatric hospital in the United States, has engaged the company to enhance access to its world-renowned providers and facilitiesFull story -
Trends From The Socially Distanced Trenches: Storage, Image Analysis, And What’s Coming For Bio-IT
May 13, 2020, 08:20 AM by Michael CroftFull storyBio-IT World | The 10th anniversary of Chris Dagdigian’s Trends from the Trenches presentation kicked off yesterday to hundreds of audience members in attendance—but this time virtually.
-
Engility® CTMS Selected by Leading US Health Outcomes and Technology Company for its Clinical Trial Programmes
May 13, 2020, 08:15 AM by Michael Croft, ENGLAND - May 12, 2020 - PHARMASEAL, a new provider of clinical trial management and governance solutions, announced today that a leading US health outcomes and technology company has selected Engility® Clinical Trial Management system for the management and oversight of its clinical trial programmesFull story -
SEKISUI XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes
May 12, 2020, 08:56 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - May 12, 2020 - SEKISUI XenoTech has been awarded US patent # 10,648,968 In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytesFull story -
Proof-of-Concept Research Demonstrates Patients Reliably Perform Remote Self-Sampling of Concerning Moles Using DermTech’s Non-Invasive Adhesive Skin Collection Kit Under Physician Supervision via Tel
May 11, 2020, 17:15 PM by Michael CroftLA JOLLA, CA, US - May 11, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that SKIN, the official journal of the National Society for Cutaneous Medicine, published proof-of-concept data demonstrating that patients are able to reliably perform remote self-sampling of concerning moles using the DermTech Pigmented Lesion Assay (the DermTech PLA) under physician supervision via telemedicine, enabling actionable molecular testing for accurate melanoma detectionFull story -
The Melanoma Research Foundation Hosting Weekly Facebook Live ‘Ask a Dermatologist’ Sessions throughout Melanoma Awareness Month
May 11, 2020, 15:26 PM by Michael CroftLA JOLLA, CA, US - May 5, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech) and the Melanoma Research Foundation (MRF) recognize Melanoma Awareness Month this May with an Ask a Dermatologist webinar series offered on MRFs Facebook page every Thursday throughout the month to raise awareness of melanoma and educate around the dangers of the fastest growing and most deadly form of skin cancerFull story -
Eli Dart On Science DMZs, COVID-19, And The Future Of Computing Infrastructure
May 11, 2020, 15:20 PM by Michael CroftFull storyBio-IT World | TRENDS FROM THE TRENCHES—At the Energy Sciences Network—ESNet—Eli Dart works to help scientists, science collaborations, and facilities more effectively use high performance networking in the conduct of science. He talks with BioTeam's Stan Gloss on the future of networks.
-
DermTech Announces Telemedicine Solution to Enable Remote Use of its Non-Invasive Adhesive Patch Test for Melanoma Detection
May 11, 2020, 15:19 PM by Michael CroftLA JOLLA, CA, US - Apr 30, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), today announced that its lead non-invasive melanoma detection test, the DermTech Pigmented Lesion Assay (the DermTech PLA), is now available for use by clinicians and their patients via telemedicineFull story -
Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials
May 11, 2020, 10:18 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - May 11, 2020 - As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designsFull story -
Rho Recognized with CRO Leadership Award from Leading Industry Publications
May 11, 2020, 10:12 AM by Michael CroftDURHAM, NC, US - May 11, 2020 - For Immediate ReleaseRho Recognized with CRO Leadership Award fromLeading Industry PublicationsResearch Triangle Park, NC - May 11, 2020 - Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has been honored with a 2020 CRO Leadership Award by leading industry publications Life Science Leader and Clinical Leader for the third timeFull story -
COVID-19 Pandemic to Heighten Market Prospects for Drug Delivery Systems: Market Set to Register Strong 7% Growth, Concludes Fact.MR
May 11, 2020, 09:56 AM by Michael CroftDUBLIN 2, IRELAND - May 11, 2020 - The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR of 7Full story -
Agendia Co-Founder and Chief Scientific Officer René Bernards, PhD Elected to the National Academy of Sciences
May 11, 2020, 09:44 AM by Michael CroftNEW YORK, NY, UNITED STATES - May 8, 2020 -Full story- Development of MammaPrint®,first FDA-cleared molecular diagnostic test for personalized treatment of breast cancer, considered a landmark achievement in breast cancer testing and treatment
-
Gene Therapy Company Dyno Therapeutics Pairs Biology With AI For Therapeutic Gains
May 11, 2020, 08:05 AM by Michael CroftFull storyBio-IT World | Dyno Therapeutics emerged from stealth mode today and announced partnerships with Novartis and Sarepta Therapeutics to develop gene therapies for eye disease and neuromuscular and cardiovascular disease.
-
Find the One-stop Bispecific Antibody Services and Products at Creative Biolabs
May 11, 2020, 04:24 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 11, 2020 - Bispecific antibody (BsAb) is a technology that has just been commercialized in the past ten years. However, its commercial prospect has already shown a bright outlook as BsAb has been considered a prospective drug for tumor and cancer treatment and a large number of projects in its research and development are underwayFull story -
Spring Bank Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results
May 8, 2020, 14:25 PM by Michael CroftHOPKINTON, MA, UNITED STATES - May 7, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, today announced its financial results for the first quarter ended March 31, 2020 and provided an update on recent corporate and clinical development highlightsFull story -
AI Predicts New COVID-19 Drugs, New Commercial COVID-19 Command Center
May 8, 2020, 10:35 AM by Michael CroftBio-IT World New research on COVID-19 treatments and vaccines from worldwide researchers at Northwestern University, Erasmus MC University Medical Center, the Russian Academy of Sciences, the University of Southern California and more. Saama Technologies and iNDX.Ai and launched the COVID-19 Command Center, and AI and supercomputing technologies flag new drugs. We round up the week’s research and industry news for COVID-19.Full story -
AI VIVO seeks collaboration partners to progress top-ranked COVID-19 therapeutic candidates
May 7, 2020, 11:02 AM by Michael CroftCAMBRIDGE, UK - May 7, 2020 -Full story- 41 of the candidate drugs from AI VIVO's top-ranked list for COVID-19 are now in clinical trials for COVID-19 by multiple groups globally
- Demonstrates the ability of AI VIVO's unique phenotypic drug discovery methodology to identify and rank therapeutic candidates
- AI VIVOselected other drugs as single and combinations from their top-ranked list and seeks partners with pharma companies and clinical trial investigators
-
CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic
May 7, 2020, 10:41 AM by Michael CroftKING OF PRUSSIA, PA, US - May 7, 2020 - CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, today announced that its recently launched complimentary COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies that are directly affected by Covid-19Full story -
KCR’s Bryan Katz named in PM360’s ELITE 100
May 7, 2020, 10:17 AM by Michael CroftBOSTON, MA - May 7, 2020 - KCR, the international clinical development solutions provider, announced today that its Chief Commercial Officer, Bryan Katz, was honored by healthcare marketing industry trade magazine PM360 as one of their 2020 ELITE 100 award winnersFull story -
Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system
May 7, 2020, 07:19 AM by Michael CroftGUILDFORD, UNITED KINGDOM - May 7, 2020 - For use in advanced medical research into inflammation, oncology and nephritis the 7T PET-MR imaging system from MR Solutions provides a combination of PET and MRI images either simultaneously or separatelyFull story